Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C
Clinical trial NCT05631249 · RECRUITING
Trial details
- NCT number
- NCT05631249
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-13
- Primary completion
- 2027-12-12
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.